Wu L, Zhan H, Bao Z N, Chen J Q, Cai X L
School of Humanities and Management, Hunan University of Chinese Medicine, Changsha 410208, China.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2022 Jul 20;40(7):515-518. doi: 10.3760/cma.j.cn121094-20210702-00320.
To explore the level and influencing factors of treatment costs for patients with pneumoconiosis, and to provide a basis for reducing the economic burden of patients with pneumoconiosis and optimizing the rational allocation of medical resources. In August 2020, the multi-stage stratified sampling method was used to obtain the treatment cost information of pneumoconiosis patients from January to December 2018 in 1123 sample medical institutions. The average cost per time of 2178 outpatients and 7425 inpatients was described, and the differences in the distribution of hospitalization costs for patients with pneumoconiosis were compared by one-way analysis of variance, and a multiple linear regression model was constructed to analyze the influencing factors of hospitalization costs for patients with pneumoconiosis. The average cost of outpatients with pneumoconiosis was 465.88 yuan, and the average cost of inpatients was 12280.63 yuan. There were statistically significant differences in hospitalization expenses among different age, institution level, institution type, length of hospital stay and type of insured (=10.49, 402.92, 416.35, 2390.48, 1298.14, <0.001) . Age, length of hospital stay, reimbursement ratio, and institution level were influencing factors of the total hospitalization expenses of patients with pneumoconiosis (=5.27, 62.20, 22.35, 21.20, <0.001) . Patients with pneumoconiosis have a heavy burden of treatment costs. Age, length of hospital stay, institution level and reimbursement ratio are the main influencing factors of hospitalization costs. It is recommended to strengthen the prevention and treatment of key populations, standardize the use of medical insurance, and promote the rational allocation of medical resource to reduce the cost burden of pneumoconiosis patients.
为探讨尘肺病患者治疗费用水平及影响因素,为减轻尘肺病患者经济负担、优化医疗资源合理配置提供依据。2020年8月,采用多阶段分层抽样方法,获取了1123家样本医疗机构2018年1月至12月尘肺病患者的治疗费用信息。描述了2178例门诊患者和7425例住院患者的次均费用,采用单因素方差分析比较尘肺病患者住院费用分布差异,并构建多元线性回归模型分析尘肺病患者住院费用的影响因素。尘肺病门诊患者次均费用为465.88元,住院患者次均费用为12280.63元。不同年龄、机构级别、机构类型、住院天数和参保类型的住院费用差异有统计学意义(=10.49, 402.92, 416.35, 2390.48, 1298.14, <0.001)。年龄、住院天数、报销比例和机构级别是尘肺病患者住院总费用的影响因素(=5.27, 62.20, 22.35, 21.20, <0.001)。尘肺病患者治疗费用负担较重。年龄、住院天数、机构级别和报销比例是住院费用的主要影响因素。建议加强重点人群防治,规范医保使用,促进医疗资源合理配置,以减轻尘肺病患者费用负担。